Lavendustin A selectively and potently inhibits EGFR (epidermal growth factor receptor) tyrosine kinase. The chemical has been observed to bind to a site on the kinase that is different from the peptide substrate and ATP binding sites. Lavendustin A is an inhibitor of c-Src.